Search
for
Sort by
Research 301–330 of 1000+
- Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque.
- Evaluation of hair loss
- Skin diseases in consequence of endocrine alterations
- Androgenic Alopecia
- 642 Uncovering the role of UV exposure history and genetics in determining skin sun damage
- Alopecias
- Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia
- Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer
- Diagnosis: Alopecia areata or not?
- Procyanidin B-2 and the hair-growing activity of proanthocyanidins
- SELF-CARE OF MALE PATTERN HAIR LOSS – Selfcare Journal
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- A Mouse Model of Androgenetic Alopecia
- Hunting the genes in male‐pattern alopecia: how important are they, how close are we and what will they tell us?
- The potential of androgenic alopecia management from plant derivatives
- Pharmacological Treatment of Alopecia
- A brief report on PCOS: and its inducing model
- Exploring the Potential of Eclipta alba: A Promising Approach for Hair Treatment Management through 5-Alpha Reductase Inhibition
- Hair, Hormones, and High-Risk Prostate Cancer
- Molecular mechanisms of androgenetic alopecia
- An Update of Congenital Adrenal Hyperplasia
- Female Pattern Hair Loss: a clinical and pathophysiological review
- The hair growth promoting effect of Sophora flavescens extract and its molecular regulation
- Dihydrotestosterone inhibits hair growth in mice by inhibiting insulin-like growth factor-I production in dermal papillae
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Novel inhibitors of 5α-reductase
- Progenitor‐cell‐enriched micrografts as a novel option for the management of androgenetic alopecia
- Future Horizons in Hair Restoration
- trans-3,4'-Dimethyl-3-hydroxyflavanone, a Hair Growth Enhancing Active Component, Decreases Active Transforming Growth Factor .BETA.2 (TGF-.BETA.2) through Control of Urokinase-Type Plasminogen Activator (uPA) on the Surface of Keratinocytes